Cargando…

PRSS1 genotype is associated with prognosis in patients with pancreatic ductal adenocarcinoma

The prognostic value of the genotype of the PRSS1 gene in patients with pancreatic ductal adenocarcinoma (PDAC) remains poorly understood. The aim of the present study was to evaluate the association between the PRSS1 genotype and clinicopathological characteristics of patients with PDAC, as well as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Huasheng, Ding, Fadian, Chen, Xijun, Chen, Shaoqin, Shi, Zhen, Liu, Qicai, Zheng, Zhenhua, Chen, Youting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924091/ https://www.ncbi.nlm.nih.gov/pubmed/31897122 http://dx.doi.org/10.3892/ol.2019.11097

Ejemplares similares

Use of the Advanced Lung Cancer Inflammation Index as a Prognostic Indicator for Patients With Cholangiocarcinoma
por: Wu, Huasheng, et al.
Publicado: (2022)

Methylation of CALCA and CALCB in Pancreatic Ductal Adenocarcinoma
por: Gao, Feng, et al.
Publicado: (2021)

DDIT4 Novel Mutations in Pancreatic Cancer
por: Ding, Fadian, et al.
Publicado: (2021)

A review of the mechanism of DDIT4 serve as a mitochondrial related protein in tumor regulation
por: Ding, Fadian, et al.
Publicado: (2021)

PRSS1 mutation: a possible pathomechanism of pancreatic carcinogenesis and pancreatic cancer
por: Liu, Qicai, et al.
Publicado: (2019)

Identifying the neck margin status of ductal adenocarcinoma in the pancreatic head by multiphoton microscopy
por: Xu, Jian, et al.
Publicado: (2017)

Adropin attenuates pancreatitis-associated lung injury through PPARγ phosphorylation-related macrophage polarization
por: Ding, Fadian, et al.
Publicado: (2023)

The Polymorphisms at PRSS1-PRSS2 and MORC4 Loci and the Risk of Post-ERCP Pancreatitis
por: Angsuwatcharakon, Phonthep, et al.
Publicado: (2018)

Role of the Common PRSS1-PRSS2 Haplotype in Alcoholic and Non-Alcoholic Chronic Pancreatitis: Meta- and Re-Analyses
por: Herzig, Anthony F., et al.
Publicado: (2020)

PRSS3 is a prognostic marker in invasive ductal carcinoma of the breast
por: Qian, Li, et al.
Publicado: (2017)

The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma
por: Lu, Hao, et al.
Publicado: (2022)

Pancreatic Ductal Adenocarcinoma: Relating Biomechanics and Prognosis
por: MacCurtain, Benjamin M., et al.
Publicado: (2021)

SPINK1, PRSS1, CTRC, and CFTR Genotypes Influence Disease Onset and Clinical Outcomes in Chronic Pancreatitis
por: Zou, Wen-Bin, et al.
Publicado: (2018)

The GALNT14 Genotype Predicts Postoperative Outcome of Pancreatic Ductal Adenocarcinoma
por: Chiang, Chun-Cheng, et al.
Publicado: (2019)

Aberrant DNA methyltransferase expression in pancreatic ductal adenocarcinoma development and progression
por: Gao, Jun, et al.
Publicado: (2013)

Development and validation of an MRI-radiomics nomogram for the prognosis of pancreatic ductal adenocarcinoma
por: Xu, Xinsen, et al.
Publicado: (2023)

Prss55 but not Prss51 is required for male fertility in mice
por: Kobayashi, Kiyonori, et al.
Publicado: (2020)

The testis-specific serine proteases PRSS44, PRSS46, and PRSS54 are dispensable for male mouse fertility(†)
por: Holcomb, Richard J, et al.
Publicado: (2020)

The coagulation-related genes for prognosis and tumor microenvironment in pancreatic ductal adenocarcinoma
por: Wang, Di, et al.
Publicado: (2023)

The genetic landscape of pancreatic head ductal adenocarcinoma in China and prognosis stratification
por: Yang, Yefan, et al.
Publicado: (2022)

PALB2 upregulation is associated with a poor prognosis in pancreatic ductal adenocarcinoma
por: Ge, Ouyang, et al.
Publicado: (2021)

Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis
por: Whitcomb, David C., et al.
Publicado: (2012)

Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma
por: Suzuoki, M, et al.
Publicado: (2002)

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Saukkonen, Kapo, et al.
Publicado: (2015)

Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma
por: Lohneis, Philipp, et al.
Publicado: (2018)

The effects of systemic inflammatory response on prognosis of pancreatic ductal adenocarcinoma
por: Aktekin, Ali, et al.
Publicado: (2019)

Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas
por: Mehta, Shreya, et al.
Publicado: (2021)

Proteome alterations in pancreatic ductal adenocarcinoma
por: Pan, Sheng, et al.
Publicado: (2020)

Identification of an unfolded protein response-related signature for predicting the prognosis of pancreatic ductal adenocarcinoma
por: Fang, Lishan, et al.
Publicado: (2023)

Distinct Spatiotemporal Expression of Serine Proteases Prss23 and Prss35 in Periimplantation Mouse Uterus and Dispensable Function of Prss35 in Fertility
por: Diao, Honglu, et al.
Publicado: (2013)

Development and validation of glycolysis‐related prognostic score for prediction of prognosis and chemosensitivity of pancreatic ductal adenocarcinoma
por: Zhang, Xiu‐Ping, et al.
Publicado: (2021)

Coexpression of EGFR and CXCR4 Predicts Poor Prognosis in Resected Pancreatic Ductal Adenocarcinoma
por: Wu, Huanwen, et al.
Publicado: (2015)

Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma
por: Tang, Rong, et al.
Publicado: (2021)

Expression of signaling adaptor proteins predicts poor prognosis in pancreatic ductal adenocarcinoma
por: Wang, Lili, et al.
Publicado: (2017)

The Effects of Radiotherapy on Pancreatic Ductal Adenocarcinoma in Patients with Liver Metastases
por: Wu, Linxia, et al.
Publicado: (2022)

Oral mycobiota and pancreatic ductal adenocarcinoma
por: Wei, Ailin, et al.
Publicado: (2022)

Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jian-Yu, et al.
Publicado: (2015)

The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma
por: Ren, Le, et al.
Publicado: (2018)

Significance of frailty in prognosis after surgery in patients with pancreatic ductal adenocarcinoma
por: Yamada, Shinichiro, et al.
Publicado: (2021)

Analysis of Methylation‐driven Genes in Pancreatic Ductal Adenocarcinoma for Predicting Prognosis
por: Zhang, Zihan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m4jq05g6h4bkac2htna2hetj8r